Prospective observational study monitors long-term cardiovascular safety of fremanezumab in migraine patients, highlighting real-world treatment tolerability.
This post-authorization safety study was developed to evaluate the long-term safety, including cardiovascular (CV) safety, of fremanezumab in real-world clinical practice.
No takes yet. Share an insight, caveat, or question.
Kahan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: